CardioMech AS is a privately held Norwegian medical technology company located in Trondheim. The company has developed a therapeutic solution for repairing mitral valve regurgitation. CardioMech´s repair solution is aimed for repairing the chords of the mitral valve and is performed minimal invasively with a transcatheter and transatrial approach. The repair technology is designed to provide patients an alternative to surgical mitral valve repair.
YEAR OF INVESTMENT
2020
SECTOR
Medical Device
LOCATION
Trondheim, Norway
WEBSITE
https://www.cardiomech.com/
Designed and developed by PageLook.no
YEAR OF INVESTMENT
2020
SECTOR
Medical Device
LOCATION
Trondheim, Norway
WEBSITE
https://www.cardiomech.com/
Designed and developed by PageLook.no
Total raised: $36.5M
Investors 1
| Date | Name | Website |
| - | Hadean Ven... | hadeanvent... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.01.2024 | - | $13M | - |
| 05.08.2020 | Series A | $18.5M | - |
| 12.08.2019 | - | $5M | - |
Mentions in press and media 11
| Date | Title | Description |
| 10.07.2025 | Norway: Sustainable, data-driven, and digitally ambitious | Norway’s tech ecosystem is maturing quietly but confidently. With world-class digital infrastructure, strong public trust, and robust government support, the country is well-positioned to lead in sustainable, data-driven innovation. Cities ... |
| 03.01.2024 | CardioMech raises $13M for transcatheter mitral chordal repair tech | CardioMech announced that it closed a $13 million financing round, bringing its total funding to $42 million to date. The Norway-based company is developing transfemoral, transeptally delivered mitral valve chordal repair technology in Frid... |
| 03.01.2024 | CardioMech Snags $13M For Its Mitral Valve Repair Tech | Medical device startup CardioMech announced this week that it has raised $13 million in new capital, bringing its total funding to $42 million. With the fresh funds, the company hopes to advance the development and validation of its flagshi... |
| 02.01.2024 | CardioMech Raises $13M in Funding | CardioMech AS, a Trondheim, Norway-based medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology, raised $13M in funding. The round, which brought the total amount to $42M, saw partic... |
| 25.03.2021 | French biotech company Step Pharma raises €35 million in Series B | Step Pharma, a Paris based biotech company, announced on 24th March 2021 that it has raised €35 million in its Series B funding round. The round was led by Sunstone Life Science Ventures and Hadean Ventures, along with participation from Ku... |
| 06.08.2020 | CardioMech AS Announces $18.5M Series A for its Transcatheter Mitral Valve Repair Technology | The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investinor, will fund CardioMech’s journey to treat patients in a first-in-human feasibility trial MINNEAPOLIS, Aug. 5, 2020 /PRNewswire/ — Minneapo... |
| 05.08.2020 | CardioMech Raises $18.5M in Series A Funding | CardioMech AS, a Trondheim, Norway-based medical device company developing a transfemoral, transseptally delivered mitral valve repair technology, raised $18.5m in Series A financing. The round was led by a non-disclosed strategic investor ... |
| 05.08.2020 | CardioMech raises $18.5M to test heart valve device in humans | CardioMech, a Norwegian medical device company with a presence in Minnesota, said today that it has secured $18.5 million in a Series A round of funding. CardioMech produces a heart valve repair device that treats degenerative mitral regurg... |
| 12.08.2019 | Transcatheter mitral valve tech dev CardioMech AS raises $5m | CardioMech AS said today that it has raised another $5 million in a heavily oversubscribed convertible note funding round, bringing its total raised during 2019 to $7.5 million. Experienced medtech investors participated in the round, whose... |
| 12.08.2019 | CardioMech Raises $5M in Funding | CardioMech AS, an Oslo, Norway-based company developing a transcatheter mitral valve repair technology, closed on a convertible note financing of $5m. The note included investments from MedTech investors and brings the total amount raised f... |
Show more